Adapalene

CAS No. 106685-40-9

Adapalene( CD 271 )

Catalog No. M10286 CAS No. 106685-40-9

Adapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 29 In Stock
50MG 37 In Stock
100MG 60 In Stock
200MG Get Quote In Stock
500MG 120 In Stock
1G 179 In Stock

Biological Information

  • Product Name
    Adapalene
  • Note
    Research use only, not for human use.
  • Brief Description
    Adapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.
  • Description
    Adapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions. It is currently marketed by Galderma under the trade names Differin in some countries, and Adaferin in India. (In Vitro):Adapalene (1-200 μM; 24 h) inhibits the viability of ES-2, HOV-7, MCF-7 , Hela, SW1990, HT1080, and MM-468 cells, with IC50s of 10.36 μM, 10.81 μM, 12.00 μM, 19.08 μM, 19.52 μM, 21.70 μM, and 31.47 μM, respectively.Adapalene (10-40 μM; 24 h) induces ES-2 cells apoptosis and inhibits proliferation in vitro.Adapalene (3-30 μM; 6-24 h) significantly increases the G1-phase population in LoVo or DLD1 cells.Adapalene (1-200 μM) inhibits GOT1 activity, with an IC50 of 21.79 μM.Adapalene (10-6-10-3 nM) inhibits the expression of plasma membrane-associated enzyme transglutaminase Type I, with an IC50 of 2.5 nM.(In Vivo):Adapalene (15-100 mg/kg; p.o. daily for 21 days) inhibits the growth of DLD1 cell-derived xenograft tumors in BALB/C nude mice.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Female BALB/C nude mice (15 g, 4-5 weeks) were injected with DLD1 cells Dosage:15, 20, 65, 100 mg/kg Administration:P.o. daily for 21 days Result:Significantly reduced tumor weight and volume.
  • Synonyms
    CD 271
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Retinoid Receptor
  • Recptor
    RAR| RXR
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    106685-40-9
  • Formula Weight
    412.52
  • Molecular Formula
    C28H28O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 8 mg/mL (19.39 mM)
  • SMILES
    COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
  • Chemical Name
    6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Brogden RN, et al. Drugs, 1997, 53(3), 511-519.
molnova catalog
related products
  • Ch55

    Ch55 is an effective inducer of the differentiation of HL60 cells (EC50 = 200 nM) and shows high affinity with RAR-α and RAR-β receptors.

  • Sodium sulfadiazine

    Sodium Sulfadiazine is a sodium salt form of sulfadiazine, an intermediate-acting bacteriostatic, synthetic sulfanilamide derivative.

  • BMS493

    BMS493 is an inverse agonist of the pan-retinoic acid receptor (RAR) that inhibits retinoic acid-induced differentiation, enhances the interaction of nuclear co-inhibitors with RARs, attenuates RA signaling, potentiates TPP-induced toxicity, and inhibits the increase in phospholipase A2 activity.